Evogene Ltd.
EVGN- Exchange
- Nasdaq
- Industry
- Agricultural Chemicals
- SEC CIK
- 0001574565
In the last 90 days, Evogene Ltd. insiders filed 3 open-market purchases and 0 sales; 13 institutions reported holding it in 13F filings for Q2 2026, worth $120.0K in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Evogene Ltd. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 28 | 35 | +7 |
| Shares | 711.0K | 4.67M | +3.95M (+556.2%) |
| Value | $759.5K | $2.73M | +$1.98M (+260.1%) |
New holders (9)
Institutions that held Evogene Ltd. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Walleye Capital LLC | 517,092 | $302.8K | 0.00% |
| CVI Holdings, LLC | 261,636 | $153.2K | 0.30% |
| The PNC Financial Services Group, Inc. | 36,000 | $21.1K | 0.00% |
| JPMorgan Chase & Co | 35,258 | $20.7K | 0.00% |
| HRT Financial LP | 15,206 | $8.00K | 0.00% |
| Millennium Management LLC | 13,648 | $7.99K | 0.00% |
| Malaga Cove Capital, LLC | 12,000 | $7.04K | 0.00% |
| Qube Research & Technologies Ltd | 50 | $29 | 0.00% |
| Toronto Dominion Bank | 20 | $12 | 0.00% |
Sold out (2)
Institutions that held Evogene Ltd. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Jane Street Group, LLC | 27,466 | $29.4K |
| Quent Capital, LLC | 12,000 | $12.8K |